FDA Warning Links Breast Implants to ALCL

March 29, 2017 – Breast implants may increase an individual’s risk of developing anaplastic large cell lymphoma, a recent FDA advisory warned. The warning follows on a statement released by the FDA in 2011 suggesting a potential link between breast implants and the rare lymphoma. The issue was subsequently researched and in 2016, the World Health Organization (WHO) recognized the correlation. “Since 2011, we have strengthened our understanding of this condition and … (leggi tutto)